Long-Term Immunogenicity and Safety of a Homologous Third Dose Booster Vaccination with TURKOVAC: Phase 2 Clinical Study Findings with 32-Week Post-Booster Follow-Up
Article in Vaccines (January 2024)
The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.
Article in Vaccines (January 2024)
Article in Diagnostics (August 2023)
Article in Viruses (April 2023)